Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The phosphatase and tensin homolog pseudogene (commonly referred to as PTENP1) is a non-protein-coding RNA gene related to the canonical PTEN tumor suppressor gene. While PTENP1 shares high sequence similarity with PTEN, it does not produce a functional phosphatase enzyme. PTENP1 and other PTEN pseudogenes can act post-transcriptionally to regulate the expression and stability of PTEN mRNA by serving as competing endogenous RNAs, thus indirectly influencing PTEN protein levels and thereby tumor biology. However, PTENP1 itself is not an established therapeutic target because it does not encode a protein product[2]. Only the canonical PTEN (phosphatase and tensin homolog) exhibits enzymatic activity with critical roles in *PI3K/AKT/mTOR signaling*, *cell proliferation*, *growth*, and *tumor suppression*[1][2][3][4][5]. Important note: The canonical target in most research and clinical contexts is Phosphatase and tensin homolog (PTEN), not the pseudogene. PTEN is a therapeutic target, tumor suppressor, and lipid/protein phosphatase involved in cell signaling, metabolism, and cancer[1][2][3][4][5]. The pseudogene (ENSG00000261882, PTENP1) is not directly targeted for therapy and does not produce an active protein[2]. There appears to be a nomenclature error or copy-paste mistake in the query as written (repetition of "phosphatase and tensin homolog" and ambiguous reference to a pseudogene).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatase and tensin homolog pseudogene (PTENP1).